data_1e5b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1e5b _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 247' ' ' THR . 1.4 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.435 -0.58 . . . . 4.5899999999999999 109.435 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -153.06 172.68 32.03 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.577 -1.409 . . . . 2.4399999999999999 109.577 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' CYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 275' ' ' TRP . 1.4 p -59.75 143.2 51.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -1.135 . . . . 1.3200000000000001 109.587 -179.883 37.26 127.942 -101.684 104.205 2.02 104.018 -94.779 -158.138 2 2 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.33 84.25 1.98 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 1.6100000000000001 109.054 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 330' ' ' CYS . 7.5 p -79.73 151.92 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.913 . . . . 1.1200000000000001 109.774 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' THR . . . . . 0.522 ' N ' HG21 ' A' ' 251' ' ' VAL . 0.0 OUTLIER -131.49 170.05 15.24 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.697 -0.853 . . . . 1.6499999999999999 108.697 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ALA . . . . . 0.634 ' CB ' ' CE1' ' A' ' 267' ' ' TYR . . . -122.03 161.09 23.61 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.412 -0.805 . . . . 1.1499999999999999 109.788 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' THR . . . . . 0.425 ' O ' ' OG1' ' A' ' 266' ' ' THR . 16.6 m -167.91 105.3 0.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 1.1799999999999999 109.379 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.519 ' CG ' ' OG1' ' A' ' 325' ' ' THR . 8.1 mtm180 -59.52 123.46 16.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 2.7200000000000002 109.593 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ALA . . . . . 0.471 ' HB1' ' O ' ' A' ' 264' ' ' ASN . . . -101.37 -86.01 0.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 1.1000000000000001 109.534 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -89.96 167.06 13.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 1.6299999999999999 109.508 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' GLU . . . . . 0.504 ' HG2' ' N ' ' A' ' 259' ' ' TRP . 24.9 tt0 -170.43 146.9 2.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 1.8999999999999999 110.128 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' TRP . . . . . 0.516 ' CE2' ' O ' ' A' ' 262' ' ' GLY . 11.2 p90 -155.49 -168.72 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 0.37 108.94 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.0 m -82.98 41.95 0.77 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 1.4099999999999999 110.079 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -156.84 -37.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.088 -1.007 . . . . 1.45 109.827 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 259' ' ' TRP . . . -174.57 169.47 42.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.32 -1.512 . . . . 0.56000000000000005 109.32 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' PHE . . . . . 0.639 ' CZ ' ' CG1' ' A' ' 317' ' ' VAL . 2.8 p90 -133.14 139.44 47.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -1.2 . . . . 2.1099999999999999 109.752 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ASN . . . . . 0.471 ' O ' ' HB1' ' A' ' 256' ' ' ALA . 88.3 m-20 -79.56 92.45 5.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.345 -0.847 . . . . 2.0499999999999998 109.48 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' VAL . . . . . 0.623 HG12 ' CE2' ' A' ' 267' ' ' TYR . 2.2 t -71.1 148.0 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.29 -0.881 . . . . 1.22 109.096 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' THR . . . . . 0.584 ' N ' HG11 ' A' ' 265' ' ' VAL . 27.6 p -129.88 96.23 4.16 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.275 -0.891 . . . . 1.1000000000000001 109.494 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' TYR . . . . . 0.634 ' CE1' ' CB ' ' A' ' 253' ' ' ALA . 44.1 m-85 -83.04 126.64 32.77 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.567 -0.901 . . . . 2.1600000000000001 108.567 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' SER . . . . . 0.472 ' HA ' ' OG1' ' A' ' 312' ' ' THR . 5.4 t -102.75 117.61 35.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.991 . . . . 1.6100000000000001 110.233 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' VAL . . . . . 0.583 HG23 ' CZ3' ' A' ' 275' ' ' TRP . 83.9 t -89.31 141.82 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 1.1000000000000001 109.358 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.504 ' N ' HG11 ' A' ' 269' ' ' VAL . 24.1 p -152.55 130.55 11.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.198 -0.939 . . . . 1.72 109.48 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 134.06 -38.8 1.79 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.528 -1.429 . . . . 0.39000000000000001 109.528 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.79 171.7 18.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -1.102 . . . . 1.46 109.609 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' SER . . . . . 0.469 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 29.7 m -98.84 -43.62 6.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.34 -0.85 . . . . 1.77 109.112 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -80.0 76.5 6.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 1.1000000000000001 108.965 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' TRP . . . . . 0.583 ' CZ3' HG23 ' A' ' 269' ' ' VAL . 54.9 p-90 -123.74 170.18 10.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.403 -0.81 . . . . 0.23999999999999999 109.562 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 330' ' ' CYS . 86.0 m -138.78 116.09 11.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.281 -0.887 . . . . 1.1299999999999999 109.371 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' VAL . . . . . 0.575 HG21 ' CE3' ' A' ' 275' ' ' TRP . 40.6 t -102.99 99.65 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.311 -0.868 . . . . 1.0700000000000001 109.66 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -70.63 107.84 4.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 1.5900000000000001 109.307 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' LEU . . . . . 0.506 HD23 ' CE2' ' A' ' 267' ' ' TYR . 13.2 mt -79.8 144.59 33.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 1.79 109.528 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.82 99.24 3.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.863 . . . . 1.0600000000000001 109.374 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 285' ' ' GLN . 3.8 mm? -60.5 170.79 1.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 1.8799999999999999 109.551 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.54 ' ND2' HG21 ' A' ' 324' ' ' THR . 0.8 OUTLIER -117.47 147.29 42.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.40000000000000002 109.481 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 58.88 -139.01 49.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.58 -1.408 . . . . 0.54000000000000004 109.58 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.1 m -92.26 14.97 14.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.325 -1.103 . . . . 1.9399999999999999 109.512 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' GLN . . . . . 0.49 ' C ' ' CG2' ' A' ' 286' ' ' THR . 66.2 mt-30 -49.43 171.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.233 -0.917 . . . . 1.3899999999999999 109.28 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.49 ' CG2' ' C ' ' A' ' 285' ' ' GLN . 1.1 p -156.31 169.87 23.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 1.1599999999999999 109.545 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ILE . . . . . 0.451 HG13 ' HD2' ' A' ' 302' ' ' ARG . 19.9 mm -95.63 107.02 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 1.1499999999999999 109.309 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLN . . . . . 0.472 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 38.0 tt0 -82.94 -33.58 26.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 2.3399999999999999 109.645 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' ALA . . . . . 0.464 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -163.39 169.35 19.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 1.0700000000000001 109.707 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' SER . . . . . 0.479 ' CB ' ' CG1' ' A' ' 315' ' ' VAL . 89.6 p -161.96 168.1 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -0.852 . . . . 1.4299999999999999 109.246 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' TRP . . . . . 0.479 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 34.2 p90 -170.03 168.68 8.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.39000000000000001 109.709 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 291' ' ' TRP . 2.0 m-20 69.58 4.16 4.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.314 -0.866 . . . . 1.24 109.716 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' ALA . . . . . 0.467 ' HB1' ' CB ' ' A' ' 313' ' ' PHE . . . -176.32 147.06 0.67 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.217 -0.927 . . . . 1.0900000000000001 109.475 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.462 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 63.0 m-80 -79.96 101.15 8.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 1.2 109.428 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' VAL . . . . . . . . . . . . . 89.1 t -105.25 137.8 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 2.0 109.486 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' THR . . . . . 0.464 ' O ' ' HB3' ' A' ' 302' ' ' ARG . 2.8 p -157.97 155.14 28.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 1.6399999999999999 109.469 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' GLY . . . . . 0.466 ' N ' ' HD3' ' A' ' 302' ' ' ARG . . . -172.65 -166.95 31.97 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.559 -1.416 . . . . 1.6000000000000001 109.559 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.46 68.87 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.266 -1.138 . . . . 3.3799999999999999 109.498 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 155.68 -96.62 0.16 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.554 -1.418 . . . . 2.1699999999999999 109.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -137.47 25.23 2.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -1.126 . . . . 2.1899999999999999 109.499 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' THR . . . . . 0.424 ' C ' ' HG2' ' A' ' 302' ' ' ARG . 1.5 p -160.51 144.65 14.01 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.227 -0.921 . . . . 1.1699999999999999 109.564 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' ARG . . . . . 0.466 ' HD3' ' N ' ' A' ' 297' ' ' GLY . 7.2 mtt-85 -138.42 136.86 36.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 3.1800000000000002 109.459 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 97.5 m -83.77 126.26 32.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 1.1299999999999999 109.538 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 277' ' ' VAL . 85.5 t -99.06 152.27 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 1.0 109.459 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' THR . . . . . 0.462 ' OG1' ' HB2' ' A' ' 294' ' ' ASN . 1.3 p -146.8 146.97 28.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 1.46 109.377 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.26 143.68 20.07 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.746 2.297 . . . . 0.73999999999999999 110.421 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -89.95 -26.6 20.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 2.1400000000000001 109.441 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 136.09 -10.1 4.17 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.468 -1.453 . . . . 1.3300000000000001 109.468 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.83 23.06 0.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -1.127 . . . . 2.8700000000000001 109.47 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -138.34 64.09 0.56 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.599 -1.4 . . . . 1.23 109.599 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . 0.452 ' O ' HG22 ' A' ' 269' ' ' VAL . 12.2 m-20 -53.85 -37.63 63.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -1.131 . . . . 1.8100000000000001 109.467 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' THR . . . . . 0.472 ' OG1' ' HA ' ' A' ' 268' ' ' SER . 85.3 m -95.17 125.57 39.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 1.05 109.401 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' PHE . . . . . 0.632 ' CZ ' ' CD2' ' A' ' 267' ' ' TYR . 4.4 p90 -111.11 167.43 10.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 2.1499999999999999 109.576 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 265' ' ' VAL . . . -145.09 134.08 5.4 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.32 -1.512 . . . . 0.25 109.32 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' VAL . . . . . 0.479 ' CG1' ' CB ' ' A' ' 290' ' ' SER . 6.4 m -141.65 151.56 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -1.165 . . . . 1.05 109.644 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 7.1 m -79.92 138.4 37.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 1.0700000000000001 109.224 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' VAL . . . . . 0.639 ' CG1' ' CZ ' ' A' ' 263' ' ' PHE . 73.6 t -108.67 108.07 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 1.1599999999999999 109.564 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' MET . . . . . 0.471 ' O ' ' HG2' ' A' ' 285' ' ' GLN . 2.6 mmt -61.56 88.36 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.158 -0.964 . . . . 1.53 108.878 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' LYS . . . . . 0.512 ' HG3' ' HA3' ' A' ' 262' ' ' GLY . 78.4 mttt -41.68 -42.64 2.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.458 -0.776 . . . . 1.3200000000000001 109.84 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.483 ' C ' ' O ' ' A' ' 319' ' ' LYS . 86.2 m-20 38.57 45.77 0.91 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.817 . . . . 0.96999999999999997 109.518 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 91.37 24.91 25.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.685 -1.366 . . . . 1.1699999999999999 109.685 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' SER . . . . . 0.51 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 2.7 m -157.81 113.27 2.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -1.193 . . . . 1.79 109.576 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' SER . . . . . 0.494 ' HA ' ' HG2' ' A' ' 319' ' ' LYS . 81.0 p -102.12 24.32 10.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.94 . . . . 1.8200000000000001 109.533 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' THR . . . . . 0.54 HG21 ' ND2' ' A' ' 282' ' ' ASN . 0.6 OUTLIER -90.51 148.05 22.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.933 . . . . 1.4199999999999999 109.776 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' THR . . . . . 0.688 ' CG2' ' HD2' ' A' ' 326' ' ' PRO . 9.9 m -72.77 148.41 89.76 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.371 -0.831 . . . . 1.1100000000000001 109.01 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' PRO . . . . . 0.688 ' HD2' ' CG2' ' A' ' 325' ' ' THR . 27.4 Cg_endo -74.5 172.23 16.57 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.447 2.098 . . . . 0.26000000000000001 110.757 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.51 149.3 23.37 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.42 -0.8 . . . . 1.0900000000000001 108.977 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ALA . . . . . 0.584 ' HB1' ' CE1' ' A' ' 267' ' ' TYR . . . -140.73 133.34 28.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.178 -0.951 . . . . 1.0800000000000001 109.697 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' THR . . . . . 0.504 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -127.2 157.32 40.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.446 -0.784 . . . . 1.1000000000000001 109.124 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' CYS . . . . . 0.551 ' HB2' HG13 ' A' ' 251' ' ' VAL . 5.2 t -140.19 166.25 25.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.184 -0.947 . . . . 0.47999999999999998 109.952 -179.653 -158.138 -94.779 -101.684 104.018 2.02 104.205 127.942 37.26 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ALA . . . . . 0.414 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -156.15 150.0 25.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.379 -0.825 . . . . 1.25 109.195 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -83.92 127.66 8.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.55 -1.42 . . . . 1.48 109.55 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.281 -1.129 . . . . 3.5099999999999998 109.481 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 247' ' ' THR . 1.4 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.435 -0.58 . . . . 4.1799999999999997 109.435 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -153.06 172.68 32.03 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.577 -1.409 . . . . 1.9199999999999999 109.577 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 275' ' ' TRP . 1.4 p -59.75 143.2 51.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -1.135 . . . . 1.3200000000000001 109.587 -179.883 37.26 127.942 -101.684 104.205 2.02 104.018 -94.779 -158.138 2 2 . 1 . 001 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.33 84.25 1.98 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 1.1699999999999999 109.054 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' VAL . . . . . 0.656 HG21 HG21 ' A' ' 277' ' ' VAL . 7.5 p -79.73 151.92 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.913 . . . . 0.28000000000000003 109.774 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -131.49 170.05 15.24 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.697 -0.853 . . . . 1.0600000000000001 108.697 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ALA . . . . . 1.016 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -122.03 161.09 23.61 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.412 -0.805 . . . . 0.39000000000000001 109.788 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.6 m -167.91 105.3 0.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.67000000000000004 109.379 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.519 ' CG ' ' OG1' ' A' ' 325' ' ' THR . 8.1 mtm180 -59.52 123.46 16.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 2.2000000000000002 109.593 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -101.37 -86.01 0.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.41999999999999998 109.534 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -89.96 167.06 13.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 1.6299999999999999 109.508 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' GLU . . . . . 0.514 ' HG2' ' N ' ' A' ' 259' ' ' TRP . 24.9 tt0 -170.43 146.9 2.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 1.8999999999999999 110.128 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' TRP . . . . . 0.516 ' CE2' ' O ' ' A' ' 262' ' ' GLY . 11.2 p90 -155.49 -168.72 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 0.35999999999999999 108.94 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.0 m -82.98 41.95 0.77 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 1.02 110.079 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -156.84 -37.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.088 -1.007 . . . . 1.45 109.827 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 259' ' ' TRP . . . -174.57 169.47 42.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.32 -1.512 . . . . 0.48999999999999999 109.32 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' PHE . . . . . 0.825 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 2.8 p90 -133.14 139.44 47.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -1.2 . . . . 1.21 109.752 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 88.3 m-20 -79.56 92.45 5.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.345 -0.847 . . . . 1.4099999999999999 109.48 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' VAL . . . . . 0.856 HG11 ' CE2' ' A' ' 267' ' ' TYR . 2.2 t -71.1 148.0 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.29 -0.881 . . . . 0.46000000000000002 109.096 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 27.6 p -129.88 96.23 4.16 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.275 -0.891 . . . . 0.34000000000000002 109.494 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 267' ' ' TYR . . . . . 1.016 ' CE1' ' HB2' ' A' ' 253' ' ' ALA . 44.1 m-85 -83.04 126.64 32.77 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.567 -0.901 . . . . 1.25 108.567 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' SER . . . . . 0.576 ' HA ' HG23 ' A' ' 312' ' ' THR . 5.4 t -102.75 117.61 35.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.991 . . . . 1.24 110.233 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' VAL . . . . . 0.698 HG21 ' CH2' ' A' ' 275' ' ' TRP . 83.9 t -89.31 141.82 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.31 109.358 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.1 p -152.55 130.55 11.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.198 -0.939 . . . . 1.3500000000000001 109.48 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 134.06 -38.8 1.79 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.528 -1.429 . . . . 0.35999999999999999 109.528 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.79 171.7 18.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -1.102 . . . . 1.0600000000000001 109.609 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' SER . . . . . 0.469 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 29.7 m -98.84 -43.62 6.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.34 -0.85 . . . . 1.3400000000000001 109.112 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -80.0 76.5 6.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.38 108.965 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' TRP . . . . . 0.698 ' CH2' HG21 ' A' ' 269' ' ' VAL . 54.9 p-90 -123.74 170.18 10.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.403 -0.81 . . . . 0.23999999999999999 109.562 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 330' ' ' CYS . 86.0 m -138.78 116.09 11.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.281 -0.887 . . . . 0.34999999999999998 109.371 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' VAL . . . . . 0.656 HG21 HG21 ' A' ' 251' ' ' VAL . 40.6 t -102.99 99.65 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.311 -0.868 . . . . 0.29999999999999999 109.66 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -70.63 107.84 4.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 1.4199999999999999 109.307 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 279' ' ' LEU . . . . . 0.793 HD11 ' CE1' ' A' ' 313' ' ' PHE . 13.2 mt -79.8 144.59 33.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 1.1699999999999999 109.528 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.82 99.24 3.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.863 . . . . 0.26000000000000001 109.374 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.652 HD12 HG13 ' A' ' 317' ' ' VAL . 3.8 mm? -60.5 170.79 1.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 1.27 109.551 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.555 ' ND2' HG22 ' A' ' 324' ' ' THR . 0.8 OUTLIER -117.47 147.29 42.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.40000000000000002 109.481 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 58.88 -139.01 49.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.58 -1.408 . . . . 0.54000000000000004 109.58 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.1 m -92.26 14.97 14.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.325 -1.103 . . . . 1.54 109.512 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' GLN . . . . . 0.516 ' O ' HG22 ' A' ' 286' ' ' THR . 66.2 mt-30 -49.43 171.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.233 -0.917 . . . . 1.3899999999999999 109.28 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 285' ' ' GLN . 1.1 p -156.31 169.87 23.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.46999999999999997 109.545 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ILE . . . . . 0.475 ' HA ' HD13 ' A' ' 287' ' ' ILE . 19.9 mm -95.63 107.02 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.51000000000000001 109.309 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLN . . . . . 0.483 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 38.0 tt0 -82.94 -33.58 26.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 2.0099999999999998 109.645 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -163.39 169.35 19.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.28999999999999998 109.707 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' SER . . . . . 0.872 ' CB ' HG12 ' A' ' 315' ' ' VAL . 89.6 p -161.96 168.1 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -0.852 . . . . 1.0800000000000001 109.246 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' TRP . . . . . 0.488 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 34.2 p90 -170.03 168.68 8.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.33000000000000002 109.709 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 313' ' ' PHE . 2.0 m-20 69.58 4.16 4.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.314 -0.866 . . . . 0.95999999999999996 109.716 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -176.32 147.06 0.67 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.217 -0.927 . . . . 0.32000000000000001 109.475 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.475 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 63.0 m-80 -79.96 101.15 8.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.85999999999999999 109.428 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' VAL . . . . . 1.083 HG22 HG22 ' A' ' 304' ' ' VAL . 89.1 t -105.25 137.8 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 1.4199999999999999 109.486 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 295' ' ' VAL . 2.8 p -157.97 155.14 28.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 1.0900000000000001 109.469 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 297' ' ' GLY . . . . . 0.476 ' N ' ' HD3' ' A' ' 302' ' ' ARG . . . -172.65 -166.95 31.97 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.559 -1.416 . . . . 1.1000000000000001 109.559 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.46 68.87 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.266 -1.138 . . . . 2.9500000000000002 109.498 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 155.68 -96.62 0.16 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.554 -1.418 . . . . 2.1699999999999999 109.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 300' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 301' ' ' THR . 0.5 OUTLIER -137.47 25.23 2.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -1.126 . . . . 1.76 109.499 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 301' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 300' ' ' SER . 1.5 p -160.51 144.65 14.01 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.227 -0.921 . . . . 0.56999999999999995 109.564 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 302' ' ' ARG . . . . . 0.476 ' HD3' ' N ' ' A' ' 297' ' ' GLY . 7.2 mtt-85 -138.42 136.86 36.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 2.6099999999999999 109.459 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 97.5 m -83.77 126.26 32.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.37 109.538 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 1.083 HG22 HG22 ' A' ' 295' ' ' VAL . 85.5 t -99.06 152.27 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.23999999999999999 109.459 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 294' ' ' ASN . 1.3 p -146.8 146.97 28.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.80000000000000004 109.377 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.26 143.68 20.07 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.746 2.297 . . . . 0.58999999999999997 110.421 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 307' ' ' ASN . 3.3 p30 -89.95 -26.6 20.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 1.9099999999999999 109.441 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 136.09 -10.1 4.17 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.468 -1.453 . . . . 1.3300000000000001 109.468 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.83 23.06 0.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -1.127 . . . . 2.5299999999999998 109.47 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -138.34 64.09 0.56 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.599 -1.4 . . . . 1.0600000000000001 109.599 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -53.85 -37.63 63.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -1.131 . . . . 1.1799999999999999 109.467 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 267' ' ' TYR . 85.3 m -95.17 125.57 39.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.23999999999999999 109.401 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' PHE . . . . . 0.793 ' CE1' HD11 ' A' ' 279' ' ' LEU . 4.4 p90 -111.11 167.43 10.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 1.25 109.576 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 314' ' ' GLY . . . . . 0.553 ' HA2' ' O ' ' A' ' 265' ' ' VAL . . . -145.09 134.08 5.4 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.32 -1.512 . . . . 0.25 109.32 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' VAL . . . . . 0.872 HG12 ' CB ' ' A' ' 290' ' ' SER . 6.4 m -141.65 151.56 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -1.165 . . . . 0.34999999999999998 109.644 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 7.1 m -79.92 138.4 37.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.48999999999999999 109.224 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' VAL . . . . . 0.825 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 73.6 t -108.67 108.07 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.44 109.564 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' MET . . . . . 0.479 ' O ' ' HG2' ' A' ' 285' ' ' GLN . 2.6 mmt -61.56 88.36 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.158 -0.964 . . . . 1.4299999999999999 108.878 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 322' ' ' SER . 78.4 mttt -41.68 -42.64 2.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.458 -0.776 . . . . 0.70999999999999996 109.84 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.483 ' C ' ' O ' ' A' ' 319' ' ' LYS . 86.2 m-20 38.57 45.77 0.91 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.817 . . . . 0.96999999999999997 109.518 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 91.37 24.91 25.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.685 -1.366 . . . . 1.1699999999999999 109.685 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 322' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 2.7 m -157.81 113.27 2.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -1.193 . . . . 1.49 109.576 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' A' ' 319' ' ' LYS . 81.0 p -102.12 24.32 10.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.94 . . . . 1.46 109.533 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' THR . . . . . 0.555 HG22 ' ND2' ' A' ' 282' ' ' ASN . 0.6 OUTLIER -90.51 148.05 22.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.933 . . . . 1.0700000000000001 109.776 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 325' ' ' THR . . . . . 0.941 HG23 ' HD2' ' A' ' 326' ' ' PRO . 9.9 m -72.77 148.41 89.76 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.371 -0.831 . . . . 0.64000000000000001 109.01 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' PRO . . . . . 0.941 ' HD2' HG23 ' A' ' 325' ' ' THR . 27.4 Cg_endo -74.5 172.23 16.57 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.447 2.098 . . . . 0.22 110.757 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.51 149.3 23.37 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.42 -0.8 . . . . 0.25 108.977 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ALA . . . . . 0.523 ' HB1' HG13 ' A' ' 277' ' ' VAL . . . -140.73 133.34 28.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.178 -0.951 . . . . 0.26000000000000001 109.697 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -127.2 157.32 40.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.446 -0.784 . . . . 0.41999999999999998 109.124 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 330' ' ' CYS . . . . . 0.518 ' HB2' HG12 ' A' ' 251' ' ' VAL . 5.2 t -140.19 166.25 25.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.184 -0.947 . . . . 0.47999999999999998 109.952 -179.653 -158.138 -94.779 -101.684 104.018 2.02 104.205 127.942 37.26 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ALA . . . . . 0.414 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -156.15 150.0 25.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.379 -0.825 . . . . 0.53000000000000003 109.195 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -83.92 127.66 8.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.55 -1.42 . . . . 1.3500000000000001 109.55 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.281 -1.129 . . . . 3.2999999999999998 109.481 -179.997 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.46 ' O ' ' OG1' ' A' ' 247' ' ' THR . 1.4 p . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.435 -0.58 . . . . 4.18 109.435 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -153.06 172.68 32.03 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.577 -1.409 . . . . 1.92 109.577 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' CYS . . . . . 0.529 ' HB3' ' HB3' ' A' ' 275' ' ' TRP . 1.4 p -59.75 143.2 51.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.271 -1.135 . . . . 1.32 109.587 -179.883 37.26 127.942 -101.684 104.205 2.02 104.018 -94.779 -158.138 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -113.33 84.25 1.98 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 1.17 109.054 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' VAL . . . . . 0.656 HG21 HG21 ' A' ' 277' ' ' VAL . 7.5 p -79.73 151.92 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -0.913 . . . . 0.28 109.774 -179.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 267' ' ' TYR . 0.0 OUTLIER -131.49 170.05 15.24 Favored 'General case' 0 C--N 1.303 -1.436 0 N-CA-C 108.697 -0.853 . . . . 1.06 108.697 -179.768 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ALA . . . . . 1.016 ' HB2' ' CE1' ' A' ' 267' ' ' TYR . . . -122.03 161.09 23.61 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.412 -0.805 . . . . 0.39 109.788 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' THR . . . . . . . . . . . . . 16.6 m -167.91 105.3 0.5 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.342 -0.849 . . . . 0.67 109.379 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.519 ' CG ' ' OG1' ' A' ' 325' ' ' THR . 8.1 mtm180 -59.52 123.46 16.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.19 -0.944 . . . . 2.2 109.593 -179.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ALA . . . . . 0.46 ' HB3' ' O ' ' A' ' 264' ' ' ASN . . . -101.37 -86.01 0.42 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.91 . . . . 0.42 109.534 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 17.6 mm-40 -89.96 167.06 13.1 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.237 -0.914 . . . . 1.63 109.508 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' GLU . . . . . 0.514 ' HG2' ' N ' ' A' ' 259' ' ' TRP . 24.9 tt0 -170.43 146.9 2.9 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.147 -0.97 . . . . 1.9 110.128 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' TRP . . . . . 0.516 ' CE2' ' O ' ' A' ' 262' ' ' GLY . 11.2 p90 -155.49 -168.72 2.91 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 0.36 108.94 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 5.0 m -82.98 41.95 0.77 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.129 -0.982 . . . . 1.02 110.079 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -156.84 -37.79 0.08 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.088 -1.007 . . . . 1.45 109.827 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' GLY . . . . . 0.516 ' O ' ' CE2' ' A' ' 259' ' ' TRP . . . -174.57 169.47 42.45 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.32 -1.512 . . . . 0.49 109.32 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' PHE . . . . . 0.825 ' CZ ' HG11 ' A' ' 317' ' ' VAL . 2.8 p90 -133.14 139.44 47.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.16 -1.2 . . . . 1.21 109.752 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ASN . . . . . 0.46 ' O ' ' HB3' ' A' ' 256' ' ' ALA . 88.3 m-20 -79.56 92.45 5.31 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.345 -0.847 . . . . 1.41 109.48 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' VAL . . . . . 0.856 HG11 ' CE2' ' A' ' 267' ' ' TYR . 2.2 t -71.1 148.0 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 121.29 -0.881 . . . . 0.46 109.096 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' THR . . . . . . . . . . . . . 27.6 p -129.88 96.23 4.16 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.275 -0.891 . . . . 0.34 109.494 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' TYR . . . . . 1.016 ' CE1' ' HB2' ' A' ' 253' ' ' ALA . 44.1 m-85 -83.04 126.64 32.77 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.567 -0.901 . . . . 1.25 108.567 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' SER . . . . . 0.576 ' HA ' HG23 ' A' ' 312' ' ' THR . 5.4 t -102.75 117.61 35.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.991 . . . . 1.24 110.233 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' VAL . . . . . 0.698 HG21 ' CH2' ' A' ' 275' ' ' TRP . 83.9 t -89.31 141.82 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -0.92 . . . . 0.31 109.358 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.1 p -152.55 130.55 11.81 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.198 -0.939 . . . . 1.35 109.48 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLY . . . . . . . . . . . . . . . 134.06 -38.8 1.79 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.528 -1.429 . . . . 0.36 109.528 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.79 171.7 18.34 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.326 -1.102 . . . . 1.06 109.609 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' SER . . . . . 0.469 ' O ' ' CD1' ' A' ' 275' ' ' TRP . 29.7 m -98.84 -43.62 6.68 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.34 -0.85 . . . . 1.34 109.112 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . -80.0 76.5 6.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.32 -0.863 . . . . 0.38 108.965 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' TRP . . . . . 0.698 ' CH2' HG21 ' A' ' 269' ' ' VAL . 54.9 p-90 -123.74 170.18 10.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.403 -0.81 . . . . 0.24 109.562 -179.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' THR . . . . . 0.482 ' O ' ' HA ' ' A' ' 330' ' ' CYS . 86.0 m -138.78 116.09 11.15 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.281 -0.887 . . . . 0.35 109.371 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' VAL . . . . . 0.656 HG21 HG21 ' A' ' 251' ' ' VAL . 40.6 t -102.99 99.65 8.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.311 -0.868 . . . . 0.3 109.66 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ASN . . . . . . . . . . . . . 33.1 t30 -70.63 107.84 4.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.188 -0.945 . . . . 1.42 109.307 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' LEU . . . . . 0.793 HD11 ' CE1' ' A' ' 313' ' ' PHE . 13.2 mt -79.8 144.59 33.4 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.218 -0.926 . . . . 1.17 109.528 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ALA . . . . . . . . . . . . . . . -137.82 99.24 3.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.32 -0.863 . . . . 0.26 109.374 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.652 HD12 HG13 ' A' ' 317' ' ' VAL . 3.8 mm? -60.5 170.79 1.27 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.293 -0.879 . . . . 1.27 109.551 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.555 ' ND2' HG22 ' A' ' 324' ' ' THR . 0.8 OUTLIER -117.47 147.29 42.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.284 -0.885 . . . . 0.4 109.481 -179.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLY . . . . . . . . . . . . . . . 58.88 -139.01 49.0 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.58 -1.408 . . . . 0.54 109.58 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' SER . . . . . . . . . . . . . 6.1 m -92.26 14.97 14.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.325 -1.103 . . . . 1.54 109.512 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' GLN . . . . . 0.516 ' O ' HG22 ' A' ' 286' ' ' THR . 66.2 mt-30 -49.43 171.33 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.233 -0.917 . . . . 1.39 109.28 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.516 HG22 ' O ' ' A' ' 285' ' ' GLN . 1.1 p -156.31 169.87 23.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.47 109.545 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ILE . . . . . 0.475 HD13 ' HA ' ' A' ' 287' ' ' ILE . 19.9 mm -95.63 107.02 19.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.271 -0.893 . . . . 0.51 109.309 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLN . . . . . 0.483 ' HB3' ' HB ' ' A' ' 316' ' ' THR . 38.0 tt0 -82.94 -33.58 26.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.216 -0.927 . . . . 2.01 109.645 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 315' ' ' VAL . . . -163.39 169.35 19.09 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.145 -0.972 . . . . 0.29 109.707 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' SER . . . . . 0.872 ' CB ' HG12 ' A' ' 315' ' ' VAL . 89.6 p -161.96 168.1 23.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.337 -0.852 . . . . 1.08 109.246 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' TRP . . . . . 0.488 ' O ' ' HB2' ' A' ' 292' ' ' ASN . 34.2 p90 -170.03 168.68 8.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.161 -0.962 . . . . 0.33 109.709 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 313' ' ' PHE . 2.0 m-20 69.58 4.16 4.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.314 -0.866 . . . . 0.96 109.716 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 305' ' ' THR . . . -176.32 147.06 0.67 Allowed 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.217 -0.927 . . . . 0.32 109.475 -179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.475 ' HB2' ' OG1' ' A' ' 305' ' ' THR . 63.0 m-80 -79.96 101.15 8.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.219 -0.926 . . . . 0.86 109.428 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' VAL . . . . . 1.083 HG22 HG22 ' A' ' 304' ' ' VAL . 89.1 t -105.25 137.8 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.287 -0.883 . . . . 1.42 109.486 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' THR . . . . . 0.58 HG23 ' O ' ' A' ' 295' ' ' VAL . 2.8 p -157.97 155.14 28.92 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 1.09 109.469 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' GLY . . . . . 0.476 ' N ' ' HD3' ' A' ' 302' ' ' ARG . . . -172.65 -166.95 31.97 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.559 -1.416 . . . . 1.1 109.559 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.46 68.87 0.05 OUTLIER 'General case' 0 C--N 1.305 -1.35 0 O-C-N 121.266 -1.138 . . . . 2.95 109.498 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' GLY . . . . . . . . . . . . . . . 155.68 -96.62 0.16 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.554 -1.418 . . . . 2.17 109.554 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 301' ' ' THR . 0.5 OUTLIER -137.47 25.23 2.91 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -1.126 . . . . 1.76 109.499 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . 0.658 HG23 ' O ' ' A' ' 300' ' ' SER . 1.5 p -160.51 144.65 14.01 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.227 -0.921 . . . . 0.57 109.564 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' ARG . . . . . 0.476 ' HD3' ' N ' ' A' ' 297' ' ' GLY . 7.2 mtt-85 -138.42 136.86 36.68 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 2.61 109.459 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' THR . . . . . . . . . . . . . 97.5 m -83.77 126.26 32.74 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.265 -0.897 . . . . 0.37 109.538 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 1.083 HG22 HG22 ' A' ' 295' ' ' VAL . 85.5 t -99.06 152.27 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.263 -0.898 . . . . 0.24 109.459 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' THR . . . . . 0.475 ' OG1' ' HB2' ' A' ' 294' ' ' ASN . 1.3 p -146.8 146.97 28.35 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.296 -0.878 . . . . 0.8 109.377 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.26 143.68 20.07 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.746 2.297 . . . . 0.59 110.421 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' ASN . . . . . 0.403 ' ND2' ' H ' ' A' ' 307' ' ' ASN . 3.3 p30 -89.95 -26.6 20.31 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.308 -0.87 . . . . 1.91 109.441 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLY . . . . . . . . . . . . . . . 136.09 -10.1 4.17 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.468 -1.453 . . . . 1.33 109.468 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.83 23.06 0.39 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.284 -1.127 . . . . 2.53 109.47 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLY . . . . . . . . . . . . . . . -138.34 64.09 0.56 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.599 -1.4 . . . . 1.06 109.599 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 12.2 m-20 -53.85 -37.63 63.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.276 -1.131 . . . . 1.18 109.467 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' THR . . . . . 0.717 HG23 ' O ' ' A' ' 267' ' ' TYR . 85.3 m -95.17 125.57 39.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.271 -0.893 . . . . 0.24 109.401 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' PHE . . . . . 0.793 ' CE1' HD11 ' A' ' 279' ' ' LEU . 4.4 p90 -111.11 167.43 10.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 1.25 109.576 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' GLY . . . . . 0.553 ' HA2' ' O ' ' A' ' 265' ' ' VAL . . . -145.09 134.08 5.4 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.32 -1.512 . . . . 0.25 109.32 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' VAL . . . . . 0.872 HG12 ' CB ' ' A' ' 290' ' ' SER . 6.4 m -141.65 151.56 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -1.165 . . . . 0.35 109.644 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' THR . . . . . 0.483 ' HB ' ' HB3' ' A' ' 288' ' ' GLN . 7.1 m -79.92 138.4 37.12 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.32 -0.863 . . . . 0.49 109.224 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' VAL . . . . . 0.825 HG11 ' CZ ' ' A' ' 263' ' ' PHE . 73.6 t -108.67 108.07 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.44 109.564 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' MET . . . . . 0.479 ' O ' ' HG2' ' A' ' 285' ' ' GLN . 2.6 mmt -61.56 88.36 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.158 -0.964 . . . . 1.43 108.878 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' LYS . . . . . 0.514 ' HA ' ' O ' ' A' ' 322' ' ' SER . 78.4 mttt -41.68 -42.64 2.59 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.458 -0.776 . . . . 0.71 109.84 -179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.483 ' C ' ' O ' ' A' ' 319' ' ' LYS . 86.2 m-20 38.57 45.77 0.91 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.817 . . . . 0.97 109.518 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' GLY . . . . . . . . . . . . . . . 91.37 24.91 25.15 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.685 -1.366 . . . . 1.17 109.685 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' SER . . . . . 0.514 ' O ' ' HA ' ' A' ' 319' ' ' LYS . 2.7 m -157.81 113.27 2.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.173 -1.193 . . . . 1.49 109.576 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' SER . . . . . 0.498 ' HA ' ' HG2' ' A' ' 319' ' ' LYS . 81.0 p -102.12 24.32 10.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.94 . . . . 1.46 109.533 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' THR . . . . . 0.555 HG22 ' ND2' ' A' ' 282' ' ' ASN . 0.6 OUTLIER -90.51 148.05 22.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.208 -0.933 . . . . 1.07 109.776 -179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' THR . . . . . 0.941 HG23 ' HD2' ' A' ' 326' ' ' PRO . 9.9 m -72.77 148.41 89.76 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.371 -0.831 . . . . 0.64 109.01 179.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' PRO . . . . . 0.941 ' HD2' HG23 ' A' ' 325' ' ' THR . 27.4 Cg_endo -74.5 172.23 16.57 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 C-N-CA 122.447 2.098 . . . . 0.22 110.757 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -99.51 149.3 23.37 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.42 -0.8 . . . . 0.25 108.977 -179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ALA . . . . . 0.523 ' HB1' HG13 ' A' ' 277' ' ' VAL . . . -140.73 133.34 28.7 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.178 -0.951 . . . . 0.26 109.697 -179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 277' ' ' VAL . 0.7 OUTLIER -127.2 157.32 40.09 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.446 -0.784 . . . . 0.42 109.124 179.816 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' CYS . . . . . 0.518 ' HB2' HG12 ' A' ' 251' ' ' VAL . 5.2 t -140.19 166.25 25.17 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.184 -0.947 . . . . 0.48 109.952 -179.653 -158.138 -94.779 -101.684 104.018 2.02 104.205 127.942 37.26 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ALA . . . . . 0.414 ' N ' ' SG ' ' A' ' 249' ' ' CYS . . . -156.15 150.0 25.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.379 -0.825 . . . . 0.53 109.195 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' GLY . . . . . . . . . . . . . . . -83.92 127.66 8.19 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.55 -1.42 . . . . 1.35 109.55 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' SER . . . . . . . . . . . . . 2.7 t . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.281 -1.129 . . . . 3.3 109.481 -179.997 . . . . . . . . 0 0 . 1 stop_ save_